91 Results for "

EMD

" in MedChemExpress (MCE) Product Catalog:
Products (91)

91 Results for "EMD" in MCE Product Catalog:

72
72 Publications Verification
Cat. No.: HY-16141
CAS No.: 188968-51-6
Synonyms: EMD 121974
Cilengitide (EMD 121974) is a BBB-permeable integrins antagonist with IC50s of 0.61 nM (ανβ3), 8.4 nM (ανβ5) and 14.9 nM (α5β1), respectively. Cilengitide inhibits the binding of ανβ3 and ανβ5 to Vitronectin with IC50s of 4 nM and 79 nM, respectively. Cilengitide inhibits TGF-β/Smad signaling, mediates PD-L1 expression. Cilengitide also induces apoptosis, shows antiangiogenic effect in the research against glioblastoma and other cancers .
72
72 Publications Verification
Cat. No.: HY-16143
CAS No.: 199807-35-7
Synonyms: EMD 121974 TFA
Target:  

Integrin Autophagy

Research Areas:  

Cancer

Cilengitide is a potent and selective integrin inhibitor for αvβ3 and αvβ5 receptor, with IC50 values of 4 nM and 79 nM, respectively.
18
18 Cited Publications
Cat. No.: HY-15193
CAS No.: 1181770-72-8
Purity:  99.94%
EMD638683 is an orally active SGK1 inhibitor with an IC50 of 3 μM. EMD638683 exhibits strong inhibition against SGK1, moderate inhibition against SGK2 and SGK3, and shows excellent selectivity for other AGC kinase family members. EMD638683 has antihypertensive activity by inhibiting SGK1, and independently of the blood pressure-lowering effect, it effectively prevents heart inflammation and fibrosis caused by hypertension by inhibiting the cardiac NLRP3 inflammation body/ IL-1β axis. EMD638683 promotes apoptosis of colon cancer cells and sensitizes radiotherapy. EMD638683 (S-Form) can be used in research related to hypertension, hypertensive heart damage, and colon cancer .
8
8 Cited Publications
Cat. No.: HY-14721
CAS No.: 1100598-32-0
Purity:  99.94%
Synonyms: EMD-1214063
Target:  

c-Met/HGFR Autophagy

Research Areas:  

Cancer

Tepotinib (EMD-1214063) is an orally active and highly selective, reversible, ATP-competitive c-Met inhibitor with an IC50 of 3 nM, >200-fold selective for c-Met than IRAK4, TrkA, Axl, IRAK1, and Mer. Tepotinib inhibits c-Met phosphorylation and induces autophagy. Tepotinib has antitumor effects .
8
8 Cited Publications
Cat. No.: HY-14771A
CAS No.: 775351-61-6
Purity:  99.98%
Synonyms: EMD 387008 hydrochloride
Imeglimin hydrochloride (EMD 387008) is an oral glucose-lowering agent. Imeglimin also reduces reactive oxygen species (ROS) production, increases mitochondrial DNA and improves mitochondrial function .
8
8 Cited Publications
Cat. No.: HY-14771
CAS No.: 775351-65-0
Synonyms: EMD 387008
Imeglimin (EMD 387008) is an oral glucose-lowering agent. Imeglimin improves insulin sensitivity. Imeglimin also reduces reactive oxygen species (ROS) production, increases mitochondrial DNA and improves mitochondrial function .
6
6 Cited Publications
Cat. No.: HY-14262
CAS No.: 163521-12-8
Purity:  99.84%
Synonyms: EMD 68843; SB659746A
Research Areas:  

Neurological Disease

Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active serotonin reuptake inhibitor (SSRI) and partial 5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders .
6
6 Cited Publications
Cat. No.: HY-14261
CAS No.: 163521-08-2
Purity:  100.70%
Synonyms: EMD 68843 Hydrochloride; SB659746A Hydrochloride
Research Areas:  

Neurological Disease

Vilazodone Hydrochloride (EMD 68843 Hydrochloride) is a serotonin transporter (SER) inhibitor and 5-HT1A receptor partial agonist.
4
4 Cited Publications
Cat. No.: HY-19273
CAS No.: 187870-78-6
Synonyms: EMD-87580
Research Areas:  

Metabolic Disease

Rimeporide (EMD-87580) is a potent and selective inhibitor of the Na +/H + exchanger (NHE-1).
2
2 Cited Publications
Cat. No.: HY-70057
CAS No.: 133865-89-1
Synonyms: FCE 26743; EMD 1195686
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 μM) . Safinamide also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 μM) than at resting (IC50=262 μM) potentials. Safinamide has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al .
2
2 Cited Publications
Cat. No.: HY-70057A
CAS No.: 202825-46-5
Synonyms: FCE 26743 mesylate; EMD 1195686 mesylate
Safinamide (FCE 26743; EMD 1195686) mesylate is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 nM) . Safinamide mesylate also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 μM) than at resting (IC50=262 μM) potentials. Safinamide mesylate has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke et.al .
2
2 Cited Publications
Cat. No.: HY-15193A
CAS No.: 1184940-47-3
Purity:  99.86%
Target:  

SGK

Research Areas:  

Cardiovascular Disease Cancer

EMD638683 R-Form is the R-form of EMD638683 (HY-15193). EMD638683 is a highly selective SGK1 inhibitor.
1
1 Cited Publications
Cat. No.: HY-101473
CAS No.: 851333-14-7
Purity:  99.94%
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

EMD527040 is a potent and highly selective αvβ6 antagonist with antifibrotic activities. EMD527040 can be used for carcinoma and liver fibrosis research .
1
1 Cited Publications
Cat. No.: HY-100820
CAS No.: 351862-32-3
Purity:  98.74%
Synonyms: EMD 128130
Research Areas:  

Neurological Disease

Sarizotan (EMD 128130) is an orally active serotonin 5-HT1A receptor and dopamine receptor agonist. Sarizotan (EMD 128130) exhibits IC50 values of 6.5 nM (rat 5-HT1A), 0.1 nM (human 5-HT1A), 15.1 nM (rat D2), 17 nM (human D2), 6.8 nM (human D3) and 2.4 nM (human D4.2), respectively .
1
1 Cited Publications
Cat. No.: HY-106150B
CAS No.: 211813-86-4
Purity:  98.97%
Synonyms: EMD-96785 hydrochloride
Research Areas:  

Cardiovascular Disease

Eniporide hydrochloride (EMD-96785 hydrochloride) is a potent Na +/H + exchange inhibitor.
Cat. No.: HY-106844A
CAS No.: 147527-31-9
Purity:  99.44%
Research Areas:  

Cardiovascular Disease

(+)-EMD 57033 is a cardiac troponin C (cTnC) activator, is a dominant Ca 2+ sensitizer. (+)-EMD 57033 binds the cardiac/slow skeletal troponin C isoform and exerts myocardial contractile promotion function .
Cat. No.: HY-P0322
CAS No.: 111119-28-9
Synonyms: EMD 56574
Target:  

Integrin

GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption .
Cat. No.: HY-15000
CAS No.: 858668-07-2
Purity:  99.55%
Target:  

Kinesin

Research Areas:  

Cancer

EMD534085 is a potent and selective inhibitor of the mitotic kinesin-5 with an IC50 of 8 nM.
Cat. No.: HY-P9969
CAS No.: 339186-68-4
Synonyms: EMD 72000

Target:  

EGFR

Research Areas:  

Cancer

Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth. Deglycosylation and the possible elimination of ADCC activity can reduce the in vivo anti-tumor activity of Mattuzumab .
Cat. No.: HY-P99183
CAS No.: 1105038-73-0
Synonyms: EMD 525797; DI17E6

Target:  

Integrin

Research Areas:  

Cancer

Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer .